openPR Logo
Press release

Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026

02-12-2020 03:09 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Global Chronic Obstructive Pulmonary Disease Drugs Market 2020

Increasing prevalence is considered the central driver fueling the global chronic obstructive pulmonary disease drugs market growth in the foreseeable future. Chronic obstructive pulmonary disease drugs (COPD) refers to a group of lung disorders characterized by severe difficulty in breathing. The most common types of COPD are bronchitis and emphysema. While chronic bronchitis inflames and narrows the bronchial tubes which causes build-up of mucus, emphysema destroys the air sacs in the lungs which obstructs breathing. Being a chronic disease, COPD requires efficient management, necessitating patients to take effective medication. With rising incidence of this condition, the demand for COPD drugs is set to spike, making it one of the leading chronic obstructive pulmonary disease drugs market trends. According to the World Health Organization (WHO), there were 251 million reported cases of COPD worldwide in 2016 and the disease caused 3.17 million global deaths in the preceding year.

The report covers:

o Global Chronic Obstructive Pulmonary Disease Drugs Market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast timeframe.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/chronic-obstructive-pulmonary-disease-drugs-market-101176

Leading Players operating in the Chronic Obstructive Pulmonary Disease Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o AstraZeneca plc
o Boehringer Ingelheim Pharmaceuticals Inc.
o Mylan N.V.
o Teva Pharmaceutical Industries Ltd.
o GlaxoSmithKline plc

Heavy Industrial Pollution to Propel the Market in North America
High pollution levels as a result of intense industrial activities will aid North America's dominance on the chronic obstructive pulmonary disease drugs market share over the forecast period. Presently, there are around 16 million people suffering from COPD in the US. Besides this, low awareness levels about COPD, excessive smoking, and rapid adoption of sedentary lifestyle will further drive the market in the region. In the developing nations of Asia-Pacific and Africa, growing prevalence of respiratory disorders will expand the COPD drugs market size in these regions. Additionally, rapid urbanization is fast emerging as a leading risk factor for COPD and other lung diseases in Asia-Pacific.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/chronic-obstructive-pulmonary-disease-drugs-market-101176

The new Fortune Business Insights(TM) report, titled "Chronic Obstructive Pulmonary Disease Drugs Market Size, Share and Global Trend By Drug Class (Bronchodilators, Steroids, Combination drugs), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), and Geography Forecast till 2026", provides valuable information on this market in the following manner:
o Comprehensive assessment of the competitive landscape of the market through company profiling, key strategies, and new product launches;
o Detailed evaluation of the regional developments influencing market growth;
o Microscopic study of the market segments; and
o Exhaustive analysis of the various drivers and challenges shaping the future of the market.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/chronic-obstructive-pulmonary-disease-drugs-market-101176

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026 here

News-ID: 1929756 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 2030
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2027 | Key Companies Profiled: BSG Glass, NSG Groupe, Schott AG
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive. Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast 2020-2027
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027. List of
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Development, Trends and Forecasts to 2027
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the